Declaración PRISMA 2020: una guía actualizada para la publicación de revisiones sistemáticas
Reads0
Chats0
TLDR
La declaracion prisma 2020 sustituye a laDeclaracion PRISMA 2020 e incluye una nueva guia of presentacion de las publicaciones that refleja los avances en los metodos para identificar, seleccionar, evaluar, Evaluar and sintetizar estudios.Abstract:
Resumen La declaracion PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses), publicada en 2009, se diseno para ayudar a los autores de revisiones sistematicas a documentar de manera transparente el porque de la revision, que hicieron los autores y que encontraron. Durante la ultima decada, ha habido muchos avances en la metodologia y terminologia de las revisiones sistematicas, lo que ha requerido una actualizacion de esta guia. La declaracion prisma 2020 sustituye a la declaracion de 2009 e incluye una nueva guia de presentacion de las publicaciones que refleja los avances en los metodos para identificar, seleccionar, evaluar y sintetizar estudios. La estructura y la presentacion de los items ha sido modificada para facilitar su implementacion. En este articulo, presentamos la lista de verificacion PRISMA 2020 con 27 items, y una lista de verificacion ampliada que detalla las recomendaciones en la publicacion de cada item, la lista de verificacion del resumen estructurado PRISMA 2020 y el diagrama de flujo revisado para revisiones sistematicas.read more
Citations
More filters
Journal ArticleDOI
Epidemiology of Renal Cell Carcinoma: 2022 Update.
Laura Bukavina,Karim Bensalah,Freddie Bray,Maria I. Carlo,Ben Challacombe,Jose A. Karam,Wassim Kassouf,Thomas J. Mitchell,Rodolfo Montironi,Timothy O'Brien,Valeria Panebianco,Ghislaine Scelo,Brian Shuch,Hendrik Van Poppel,Christopher D. Blosser,Sarah P. Psutka +15 more
TL;DR: In this paper , a systematic review was conducted via Medline (PubMed) and Scopus to include meta-analyses, reviews, and original studies regarding renal cell carcinoma, epidemiology, and risk factors.
Journal ArticleDOI
Resveratrol and neuroprotection: an insight into prospective therapeutic approaches against Alzheimer’s disease from bench to bedside
Fahadul Islam,Mohamed H Nafady,Md. Rezaul Islam,Susmita Saha,Salma Rashid,Aklima Akter,MD.Harun Or-Rashid,Muhammad Akhtar,Asma Perveen,Ghulam Md Ashraf,Md. Habibur Rahman,Sherouk Hussein Sweilam +11 more
TL;DR: A better knowledge of resveratrol's mechanism of action and its promising therapeutic efficacy in treating AD is highlighted and the therapeutic potential of res veratrol as an AD therapeutic agent, which is effective against neurodegenerative disorders is highlighted.
Journal ArticleDOI
Immunogenicity and Safety of Homologous and Heterologous Prime–Boost Immunization with COVID-19 Vaccine: Systematic Review and Meta-Analysis
Haoyue Cheng,Zhicheng Peng,Shuting Si,Xialidan Alifu,Haibo Zhou,Pei Yun Chi,Yan Zhang,Minjia Mo,Yunxian Yu +8 more
TL;DR: It is suggested that now, only individuals primed with inactivated vaccines require a booster dose, and the administration of the booster dose effectively recalled specific immune responses to SARS-CoV-2 and increased antibody levels, especially in heterologous immunization.
Journal ArticleDOI
Theoretical evaluation of Cleome species' bioactive compounds and therapeutic potential: A literature review.
Anuradha Khuntia,Miquel Martorell,Kaliappan Ilango,Simona Bungau,Andrei Nadu,Tapan Behl,Javad Sharifi-Rad +6 more
TL;DR: A comprehensive perspective on a wide range of bioactive compounds identified from diverse Cleome species, emphasizing the correlation of natural active substances with potential pharmacological activities that can contribute to the improvement of therapeutic management for a range of pathologies, is presented in this article .
Journal ArticleDOI
Green Buildings as a Necessity for Sustainable Environment Development: Dilemmas and Challenges
TL;DR: In this article , a comprehensive assessment in a distinctive way of green buildings in the context of sustainable development, clarifying notions and principles of application while integrating green materials and circular economy into the general scientific framework provided.
References
More filters
Journal ArticleDOI
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
TL;DR: Moher et al. as mentioned in this paper introduce PRISMA, an update of the QUOROM guidelines for reporting systematic reviews and meta-analyses, which is used in this paper.
Journal ArticleDOI
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
TL;DR: A structured summary is provided including, as applicable, background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions and implications of key findings.
Journal ArticleDOI
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
Alessandro Liberati,Douglas G. Altman,Jennifer Tetzlaff,Cynthia D. Mulrow,Peter C Gøtzsche,John P. A. Ioannidis,Mike Clarke,Mike Clarke,Philip J. Devereaux,Jos Kleijnen,David Moher +10 more
TL;DR: An Explanation and Elaboration of the PRISMA Statement is presented and updated guidelines for the reporting of systematic reviews and meta-analyses are presented.
Book
Cochrane Handbook for Systematic Reviews of Interventions
Julian P T Higgins,Sally Green +1 more
TL;DR: The Cochrane Handbook for Systematic Reviews of Interventions is the official document that describes in detail the process of preparing and maintaining Cochrane systematic reviews on the effects of healthcare interventions.